Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Current Deferred Tax Assets (2018 - 2020)

Avai Bio's Current Deferred Tax Assets history spans 3 years, with the latest figure at -$14078.0 for Q1 2020.

  • On a quarterly basis, Current Deferred Tax Assets rose 15.1% to -$14078.0 in Q1 2020 year-over-year; TTM through Mar 2020 was -$14078.0, a 15.1% increase, with the full-year FY2020 number at -$14078.0, up 15.1% from a year prior.
  • Current Deferred Tax Assets hit -$14078.0 in Q1 2020 for Avai Bio, up from -$16582.0 in the prior quarter.
  • Over the last five years, Current Deferred Tax Assets for AVAI hit a ceiling of -$155.0 in Q1 2018 and a floor of -$16582.0 in Q1 2019.
  • Historically, Current Deferred Tax Assets has averaged -$8029.2 across 3 years, with a median of -$7689.8 in 2020.
  • Biggest five-year swings in Current Deferred Tax Assets: crashed 10598.06% in 2019 and later grew 15.1% in 2020.
  • Tracing AVAI's Current Deferred Tax Assets over 3 years: stood at -$1301.6 in 2018, then tumbled by 1173.96% to -$16582.0 in 2019, then increased by 15.1% to -$14078.0 in 2020.
  • Business Quant data shows Current Deferred Tax Assets for AVAI at -$14078.0 in Q1 2020, -$16582.0 in Q1 2019, and -$1301.6 in Q2 2018.